FRANKFURT (dpa-AFX) - The prospect of a settlement for Synlab's minority shareholders by majority shareholder Cinven drove up the share price on Friday. It rose by 4.2 percent to 11.04 euros and reached its highest level since the end of March.

The private equity investor Cinven has submitted a purchase offer to the remaining shareholders of the laboratory services provider for their shares and intends to delist the company from the stock exchange. According to Cinven, it holds around 86 of Synlab's shares. The offer is not subject to any conditions./bek/jha/